앱토크롬
109960KOSDAQ기타 전문 도매업63.3 / 100
Reference Date: 2026-06-10
Company InformationBased on 2025 Annual Report
Business Overview
AppTalkrom primarily engages in pharmaceutical distribution, including topical and digestive medications, and real estate leasing. Its subsidiary, Aprogen Inc., specializes in nuclear power plant insulation systems. In 2024, the company achieved pharmaceutical sales of 7,380 million won, insulation business revenue of 8,459 million won, and total sales of 16,400 million won.
Number of Employees
16people
Average Salary
53.3M KRW
Score Calculation Basis
Detailed Financial Score
Half of industry avg (excellent)
Well below industry avg
Half of industry avg (excellent)
Avg ▼18.9% (2-year basis)
Avg ▲38.0% (2-year basis)
Avg ROE -3.2% (declining, 3yr)
Detailed News Sentiment
- Negative앱토크롬, 6WR 신주인수권 행사기간 만료 및 상장폐지 예고
앱토크롬의 신주인수권 행사기간 만료로 인해 상장폐지 예고로 인해 투자자들의 불안감 증가.
Detailed Momentum
52w upper range (78%)
1m +1094.77% (strong rise)
Volume flat
Detailed Disclosure
- Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-06-05
- Neutral[기재정정]주권관련사채권의취득결정2026-06-02
- Neutral주권매매거래정지해제 (감자 주권 변경상장)2026-05-27
- Neutral주권관련사채권의취득결정2026-05-26
- Neutral기타시장안내 (앱토크롬 6WR 신주인수권 행사기간 만료 및 상장폐지 예고)2026-05-22
